Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: Examination of a preemptive plan of ganciclovir therapy

American Journal of Hematology

Volumn 51, Issue 2, 1996, Pages 104-111

  Mandanas, Romeo A ^a   Saez, Ruben A ^a   Selby, George B ^a   Confer, Dennis L ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Allogeneic; Bone marrow transplant; Cytomegalovirus; Ganciclovir; Pneumonia

Indexed keywords

GANCICLOVIR;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CLINICAL ARTICLE; CYTOMEGALOVIRUS; FEMALE; HUMAN; LUNG LAVAGE; MALE; PNEUMONIA; PRIORITY JOURNAL; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030047884     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199602)51:2<104::AID-AJH2>3.0.CO;2-1     Document Type: Article

References (35)

1. Winston DJ, Ho WG, Champlin RE: Cytomegalovirus infections after allogeneic bone marrow transplantation. Rev Infect Dis 12:776, 1990.
2. Reed EC, Bowden RA, Dandliker PS, Lilleby KE, Meyers JD: Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants Ann Intern Med 109:783, 1988.
3. Winston DJ, Gale RP: Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s. Bone Marrow Transplant 8:7, 1991.
4. Schmidt GM: Treatment of CMV infections and disease in transplantation Transplant Proc 23:126, 1991.
5. Emanuel DJ: Use of immunotherapy for control of human cytomegalovirus-associaled diseases Transplant Proc 23:144, 1991.
6. Schmidt GM: Prophylaxis of cytomegalovirus infection after bone marrow transplantation. Semin Oncol 19:20, 1992.
7. Forman SJ, Zaia JA: Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: Where do we stand? Blood 9:2392, 1994.
8. Elfenbein GJ, Siddiqui T, Rand KH, Graham-Pole J, Marcus RB, Mendenhall NP, Goedert TM, Wikle-Fisher T, Gross SA, Weiner RS: Successful strategy for prevention of cytomegalovirus interstitial pneumonia after human leukocyte antigen-identical bone marrow transplantation. Rev Infect Dis 12:805, 1990.
9. Miller WJ, McCullough J, Balfour HH Jr, Haake RJ, Ramsay NKC, Goldman A, Bowman R, Kersey J: Prevention of cytomegalovirus infection following bone marrow transplantation: A randomized trial of blood product screening. Bone Marrow Transplant 7:227, 1991.
10. Bowden RA, Slichter SJ, Sayers MH, Mori M, Cays MJ, Meyers JD: Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood 78:246, 1991.
11. Bowden RA: Cylomegalovirus infections in transplant patients: Methods of prevention of primary cytomegalovirus. Transplant Proc 23:136, 1991.
12. Winston DJ, Ho WG, Lin C-H, Bartoni K, Budinger MD, Gale RP, Champlin RE: Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med 106:12, 1987.
13. Sullivan KM, Kopecky KJ, Jocom J: Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 323:705, 1990.
14. Snydman DR: Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease. Rev Infect Dis 12:839, 1990.
15. Bowden FA, Fisher LD, Rogers K, Cays M, Meyers JD: Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant. J Infect Dis 164:483, 1991.
16. Atkinson K, Downs K, Golenia M: Prophylactic use of ganciclovir in allogeneic bone marrow transplantation. Absence of clinical cytomegalovirus infection. Br J Haematol 79:57, 1991.
17. Von Bueltzinsloewen A, Bordigoni P, Witz F, Bene MC, Schmitt C, Lacour B, Sommelet D: Prophylactic use of ganciclovir for allogeneic bone marrow transplantation recipients Bone Marrow Transplant 12:197, 1993.
18. Winston DJ, Ho WG, Bartoni K, DuMond C, Ebeling DF, Buhles WC, Champlm RE: Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial. Ann Intern Med 118:179, 1993.
19. Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD: Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 118.173, 1993.
20. Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA, City of Hope-Stanford-Syntex CMV Study Group: A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 324:1005, 1991.
21. Goodrich JM, Mori M, Gleaves CA, DuMond C, Cays M, Ebeling DF, Buhles WC, DeArmond B, Meyers JD: Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 325:1601, 1991.
22. Webster A, Blizzard B, Pillay D, Prentice HG, Pothecary K, Griffiths PD: Value of routine surveillance cultures for detection of CMV pneumonitis following bone marrow transplantation. Bone Marrow Transplant 12:477, 1993.
23. Robbins RA, Linder J, Stahl MG, Thompson AB III, Haire W, Kessinger A, Armitage JO, Arneson M, Woods G, Vaughan WP, Rennard SI: Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med 87:511, 1989.
24. Chao NJ, Duncan SR, Long GD, Horning SJ, Blume KG: Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Ann Intern Med 114:145, 1991.
25. Ljungman P, De Bock R, Cordonnier C, Einsele H, Engelhard D, Grundy J, Locasciulli A, Reusser P, Ribaud P: Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: A report from the Working Party for Infectious Diseases of the EBMT. Bone Marrow Transplant 12:399, 1993.
26. Meyers JD, Ljungman P, Fisher LD: Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: Importance of cytomegalovirus viremia J Infect Dis 162:373, 1990.
27. The TH, Van Der Bij W, Van Der Berg AP, Van Der Giessen, Weits J, Sprenger HG, Van Son WJ: Cytomegalovirus antigenemia. Rev Infect Dis 12:737, 1990.
28. Chou S: Newer methods for diagnosis of cytomegalovirus infection. Rev Infect Dis 12:727, 1990.
29. The TH, Van Der Ploeg M, Van Den Berg P, Vlieger AM, Van Der Giessen M, Van Son WJ: Direct detection of cytomegalovirus in peripheral blood leukocytes - A review of the antigenemia assay and polymerase chain reaction. Transplantation 54:193, 1992.
30. Boeckh M, Bowden RA, Goodrich JM, Pettinger M, Meyers JD: Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 80:1358, 1992.
31. Sisson JH, Thompson AB, Anderson JR, Robbins RA, Spurzem JR, Spence PR, Reed EC, Armitage JO, Vose JM, Arneson MA, Vaughan WP, Rennard SI: Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin disease. Am Rev Respir Dis 146:439, 1992.
32. Weiner RS, Bortin MM, Gale RP, Gluckman E, Kay HEM, Kolb HJ, Hartz AJ, Rimm AA: Interstitial pneumonitis after bone marrow transplantation: Assessment of risk factors. Ann Intern Med 104:168, 1986.
33. Ho M: Epidemiology of cytomegalovirus infections. Rev Infect Dis 12:701, 1990.
34. Winston DJ, Ho WG, Howell CL, Miller MJ, Mickey R, Martin WJ, Lin C-H, Gale RP: Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med 93:671, 1980.
35. Li C-R, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR: Recovery of HLA-restricted cylomegalovirus (CMV)-specific T-cell responses after allogeneic hone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83:1971, 1994